Viewing Study NCT01840592


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2025-12-27 @ 8:30 AM
Study NCT ID: NCT01840592
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-05-02
First Post: 2013-04-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module